Back

Secondary cardiovascular disease prevention: what have we learnt from recent clinical trials?

28 August 2017 (13:17 - 13:32)
Organised by:
Congress Presentation Part of: Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol Atherosclerosis Open Access ESC Congress 2017

About the speaker

Photo
Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

6 More presentations in this session

Presentation thumbnail
Welcome - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.
Professor T. Luescher (London, GB)
Slides Video
Presentation thumbnail
Atherosclerosis and the cardiovascular continuum.
Professor P. Libby (Boston, US)
Slides Video
Presentation thumbnail
What are the unmet medical needs in secondary cardiovascular disease prevention?
Professor P. Steg (Paris, FR)
Slides Video
Presentation thumbnail
Cardiovascular residual risk: what are the markers?
Professor W. Koenig (Munich, DE)
Slides Video
Presentation thumbnail
Audience Q&A and panel discussion - Atherosclerosis and secondary cardiovascular disease prevention: inflammation and LDL-cholesterol.
Professor P. Libby (Boston, US)
Slides Video

Access the full session

Session thumbnail
Atherosclerosis and secondary cardiovascular disease prevention: inflammation and low density lipoprotein (LDL)-cholesterol

The Event

Event poster

ESC Congress 2017

28 August 2017 13:17 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources